Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NAMPT | P43490 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18229944 | 1.00 | TAS1R3 (0.41) | TAS1R3TAS1R1ALDH1A1KDM4EPKM | |
| SCHEMBL524069 | 1.00 | TAS1R3 (0.41) | TAS1R3TAS1R1ALDH1A1KDM4EPKM | |
| SCHEMBL22291993 | 0.85 | TAS1R3 (0.42) | TAS1R3TAS1R1ALDH1A1KDM4EPKM | |
| SCHEMBL3077142 | 0.79 | L3MBTL1 (0.38) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL4035792 | 0.77 | CYP3A4 (0.31) | — | |
| SCHEMBL4035794 | 0.77 | CYP3A4 (0.31) | — | |
| SCHEMBL12348342 | 0.77 | ALDH1A1 (0.40) | ALDH1A1KDM4E | |
| SCHEMBL3064720 | 0.77 | ATM (0.41) | ALDH1A1KDM4ETDP1SMN1; SMN2 | |
| SCHEMBL3064719 | 0.77 | ATM (0.41) | ALDH1A1KDM4ETDP1SMN1; SMN2 | |
| SCHEMBL17289201 | 0.76 | TAS1R3 (0.41) | TAS1R3TAS1R1ALDH1A1KDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10730986-B2 | Molecularly imprinted polymers | PHASE HOLOGRAPHIC IMAGING PHI AB (SE) | 2020-08-04 | — | — | US | disclosed |
| US-20160288090-A1 | MOLECULARLY IMPRINTED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-10-06 | — | — | US | disclosed |
| US-20160288090-A1 | MOLECULARLY IMPRINTED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-10-06 | — | — | US | disclosed |
| EP-2391658-B1 | MOLECULARLY IMPRINTED POLYMERS | COMMW SCIENT IND RES ORG (AU) | 2015-09-23 | — | — | EP | disclosed |
| US-20130171066-A1 | POLYMERIC COMPLEMENTS TO A B-AMYLOID PEPTIDES | SELLERGREN BOERJE (DE) | 2013-07-04 | — | — | US | disclosed |
| US-20130171066-A1 | POLYMERIC COMPLEMENTS TO A B-AMYLOID PEPTIDES | SELLERGREN BOERJE (DE) | 2013-07-04 | — | — | US | disclosed |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2012-03-01 | — | — | US | disclosed |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160288090-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | TAS1R3 1904/4885TAS1R1 2936/4885ALDH1A1 1036/4885 |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | TAS1R3 1904/4885TAS1R1 2936/4885ALDH1A1 1036/4885 |
| US-10730986-B2 | Molecularly imprinted polymers | SIGLEC7, CD44, MPI | TAS1R3 1511/4885TAS1R1 1723/4885ALDH1A1 1071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.